39th Annual Update in Gastroenterology and Hepatology for the Primary Care Provider

39th Annual Update in Gastroenterology and Hepatology for the Primary Care Provider is organized by UC Davis Conference and Event Services (CES) and will be held from Nov 02 - 03, 2019 at Hyatt Regency Monterey Hotel and Spa on Del Monte Golf Course, Monterey, California, United States of America.

Target Audience:
This national conference is designed to meet the educational needs of primary care physicians, specialty physicians, nurse practitioners, physician assistants, nurses, and pharmacists.

Accreditation:
Physician Credit:
The University of California, Davis, Health designates this live activity for a maximum of 10 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse:
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ (report a maximum of 10 hours of credit and fill in “CME Category 1” for the provider number).

Learning Objectives:
At the conclusion of this activity, participants should be able to:
• Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): Learners will demonstrate understanding of NAFLD/NASH epidemiology, diagnosis of NAFLD/NASH, and treatment options available.
• Liver Cancer: Learners will understand the liver cancer screening guidelines for patients with chronic liver disease to diagnose liver cancer at an early stage and the various treatment paradigms that exist for the liver cancer.
• Chronic Hepatitis C (CHC): Learners will become familiar with the new CHC treatment regimens and which one to use for each given case of CHC.
• Recurrent Clostridium Difficile Infection: Learners will understand how to diagnose recurrent C. diff infection and prescribe the correct antibiotic regimen to treat recurrent infection.